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Background: This investigation describes the relationship between glutathione peroxidase activities, an antioxidant enzyme, 
and the oxidative status in diabetic rat blood. Methods: Malondialdehyde level and glutathione peroxidase activity were 
measured by spectrophotometric techniques. Results and conclusions: Malondialdehyde content in the diabetic rats group was 
increased compared to that in the controls [3.08 F 0.32 (mean F S.E.) vs. 1.15 F 0.29 mmol/g hemoglobin, P >0.01]. 
Glutathione peroxidase activity in the diabetic rats group was increased compared to that in the control [10.27 F 1.39 
(mean F S.E.) vs. 3.14 F 0.38 Amol NADPH/min/g hemoglobin, P>0.01]. Our results show a positive correlation between 
serum glutathione peroxidase and malondialdehyde concentration in diabetic rats. D 2003 Elsevier B.V. All rights reserved. Keywords: Oxidative damage; Glutathione peroxidase activity; Diabetic; Rat; Glucose; Malondialdehyde; Antioxidant enzyme; Oxygen free 
radicals 
1. Introduction individuals, the generation of ROS appears to be There is much evidence that reactive oxygen mol­
ecules contribute to organ injury in many systems, 
including the heart, liver, and central nervous system 
[1–3]. Oxygen free radicals have also been implicated 
in ischemia–reperfusion renal failure and acute toxin-
induced nephropathy [4–6]. Reactive oxygen species 
(ROS) are constantly formed in the human body and 
removed by an antioxidant defense system. In healthy * Correspondence author. Tel.: +98-111-2229591; fax: +98­
111-2290181. 
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ved. approximately in balance with antioxidant defense. 
An imbalance between ROS and antioxidant defenses 
in favor of the former has been described as oxidative 
stress. In some human disease, increased oxidative 
stress may make an important contribution to disease 
pathology [7,8]. ROS are generally cytotoxic, because 
of the oxidative damage they can cause to cellular 
components. However, at low concentrations, ROS 
may function as physiological mediators of cellular 
response. For example, hydrogen peroxide mimics the 
stimulatory effects of insulin on glucose transport and 
lipid synthesis in adipocytes [9]. Oxidative stress, 
which is associated with the formation of lipid per­
oxides, is suggested to contribute to pathological 
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 processes in aging and many diseases, such as diabe­
tes, atherosclerosis and cataract [10]. Increased oxi­
dative stress as a result of increased free radical 
formation has also been suggested as a contributor 
to vascular damage in diabetes [11 – 13]. Small
amounts of (ROS), including hydroxyl radicals 
('OH), superoxide anions (O2') and hydrogen perox­
ide (H2O2), are constantly generated in aerobic organ­
isms in response to both external and internal stimuli 
[14–17]. In contrast, high doses and/or inadequate 
removal of ROS result in oxidative stress, which may 
cause server metabolic malfunction and damage to 
biological macromolecules [17,18]. Oxidative stress, 
superoxide production and an imbalance in antioxi­
dant enzymes has been related with many other 
specific pathologies as chronic granulomatous dis­
ease, diabetic complications, hepatitis, rheumatoid 
arthritis, influenza virus, ulcer, pneumonia, HIV in­
fection, cataract and glaucoma [18,19]. The objective 
of this study is to illustrate the relationship between an 
antioxidant enzyme, glutathione peroxidase and oxi­
dative status, malondialdehyde level.  2. Materials and methods 
2.1. Materials 
EDTA, sodium chloride and thiobarbituric acid 
were purchased from Sigma (St. Louis, MO, USA). 
Other reactives such as streptozotocin were purchased 
from Merck (Germany). 
2.2. Animals 
All animals survived the study without signs of 
illness. Male Wistar rats, 10 weeks old and between 
220 and 260 g in body weight, were randomly 
assigned to two groups. One group of rats (diabetic 
group) received a single tail-vein injection of strepto­
zotocin (50 mg/kg) under light anesthesia with diethyl 
ether. Streptozotocin was dissolved in a citrate solu­
tion (0.15 mol/l citric acid and 0.25 mol/l sodium 
phosphate, pH 4.6). It takes 1 month for the proposed 
model to achieve diabetes. Control group received an 
equivalent volume of 0.15 mol/l citrate buffer alone. 
Control and diabetic rats were caged separately but 
housed under similar conditions. Both groups of animals were fed with the same diet and water ad 
libitum. Blood samples for analyses were collected 
after 3 months between 7:00 and 8:00 am from each 
animal. On the day of the experiments, a blood plasma 
sample was collected and malondialdehyde, glucose 
level, and glutathione peroxidase activity were deter­
mined. The glucose concentration of plasma was 
measured by Trinder’s method [20]. 
2.3. Sample 
Venous peripheral blood samples (1 ml) from rats 
were collected in EDTA-coated tubes. Erythrocytes 
were separated from plasma and mononuclear cells 
by centrifugation (10 min at 1500 x g) and washed 
three times with isotonic saline by centrifugation at 
1500 x g. After the final wash, the red blood cells 
were lysed by hypotonic shock using cold distilled 
water. Different dilution was used as hemolysate. 
2.4. Determination of malondialdehyde 
Concentration of malondialdehyde was measured 
by the thiobarbituric acid test [21]. Results  were
expressed as mmol thiobarbituric acid reactive sub­
stances/g hemoglobin. 
2.5. Assay of glutathione peroxidase 
Glutathione peroxidase activity was determined 
according to the previously reported method [22]. 
An enzyme unit was defined as the amount of enzyme 
that catalyzes the release of Amol NADPH/min at 37 
jC. Specific activity was in terms of units per gram 
hemoglobin. The amount of hemoglobin was deter­
mined by Merck test cat. no. 3317. 3. Results 
Body weight in diabetic and non-diabetic rats is 
shown in (Fig. 1). All rats injected with streptozotocin 
developed severe diabetes as indicated by increasing 
plasma glucose level (range 228–283 mg/dl). Plasma 
glucose levels in diabetic rats were elevated approx­
imately threefold as compared with controls. Plasma 
glucose concentration in diabetic and non-diabetic rats 
is shown in (Fig. 2) .Hemoglobin content in the 
81 D. Qujeq et al. / Clinica Chimica Acta 340 (2004) 79–83 
Fig. 1. Body weight in diabetic (column 1) and control rats (column 
2). Each column represents the mean value F S.E., P >0.01. 
Fig. 3. Malondialdehyde level in diabetic (column 1) and control rats 
(column 2). Each column represents the mean value F S.E., P >0.01. diabetic rats group was 1.96 F 0.03 mmol/l and in the 
control 2.04 F 0.04 mol/l. Malondialdehyde content 
in the diabetic rats group was increased compared to 
that in the control [3.08 F 0.32 (mean F S.E.) vs. 
1.15 F 0.29 mmol/g hemoglobin, P>0.01] (Fig. 3). 
Glutathione peroxidase activity in the diabetic rats 
group was increased compared to that in the control 
[10.27 F 1.39 (mean F S.E.) vs. 3.14 F 0.38 Amol 
NADPH/min/g hemoglobin, P>0.01] (Fig. 4). Fig. 5 Fig. 2. Plasma glucose concentration in diabetic (column 2) and 
control rats (column 1). Each column represents the mean 
value F S.E., P >0.01. shows relationship between malondialdehyde level 
and glutathione peroxidase activity in diabetic rats 
( y = 0.61x F 0.53, r = 0.88). There was a positive Fig. 4. Glutathione peroxidase activity in diabetic (column 1) and 
control rats (column 2). 
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Fig. 5. Relationship between malondialdehyde level and glutathione 
peroxidase activity ( y = 0.61x F 0.53, r = 0.88, P < 0.05). correlation between malondialdehyde level and gluta­
thione peroxidase activity. 4. Discussion 
As previously demonstrated, reactive oxygen spe­
cies generated during metabolism can enter into 
reactions that, when uncontrolled, can affect certain 
processes leading to clinical manifestations [2,5,7]. 
Reactive oxygen species are key participants in dam­
age caused by diabetic complications. Oxidative 
stress, superoxide production and an imbalance in 
antioxidant enzymes have been related to diabetic 
complications. Diabetes is one of the pathological 
processes known to be related with an unbalanced 
production of reactive oxygen species, such as hy­
droxyl radicals (HO'), superoxide anions (O2 ') and 
hydrogen peroxide (H2O2). Therefore, cells must be 
protected from this oxidative injury by antioxidant 
enzymes. Glutathione peroxidase catalyses the reduc­
tion of hydroperoxides using glutathione, thereby 
protecting mammalian cells against oxidative damage. 
Also, glutathione peroxidase, active in reactive oxy­
gen species neutralization and within cells, removes 
superoxide and peroxides before they react with metal 
catalysis to form more reactive species. Determination 
of malondialdehyde by thiobarbituric acid is used as an index of the extent of lipid peroxidation. As 
previously demonstrated, malondialdehyde used as 
the best available measure of global reactive oxygen 
species was substantially elevated in diabetes [11– 
13]. In the present study, we found significantly 
increased glutathione peroxidase activity and malon­
dialdehyde concentrations in diabetic rats as com­
pared with control subjects. Our results confirm 
previous data of an enhanced reactive oxygen species 
level in diabetes mellitus [8,11,14]. Higher amounts of 
reactive oxygen species play a role in the diabetic 
complications as well as in a number of disease states. 
As a safeguard against the accumulation of reactive 
oxygen species, enzymatic antioxidant activities exist. 
Therefore, when oxidative stress arises as conse­
quence of a pathologic event, a defense system 
promotes the regulation and expression of antioxidant 
enzyme such as catalase and glutathione peroxidase. 
Our results demonstrate that serum glutathione per­
oxidase activity correlates positively with malondial­
dehyde level in diabetes. Our findings of the positive 
relationship of glutathione peroxidase activities and 
serum malondialdehyde concentrations may support 
an idea of an imbalance between the antioxidant 
enzymes system and reactive oxygen species level 
in diabetes. An overproduction of reactive oxygen 
species, especially in diabetes, cannot be properly 
balanced by the antioxidant enzymes. References 
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